Summary

Persistence Market Research has recently released a detailed report on the India Malaria Diagnostics Market for the forecast period 2025–2032. This comprehensive report offers an in-depth analysis of key market dynamics-drivers, trends, opportunities, and challenges-providing stakeholders with essential insights into the structure and future trajectory of the market.

Key Insights:

• India Malaria Diagnostics Market Size (2025E): US$ 61.6 Mn
• Projected Market Value (2032F): US$ 81.6 Mn
• Global Market Growth Rate (CAGR 2025 to 2032): 4.1 %

Scope of the Report: India Malaria Diagnostics Market

The India malaria diagnostics market encompasses a range of diagnostic technologies aimed at early and accurate detection of malaria infections caused by Plasmodium species. Key diagnostic technologies covered include traditional microscopy, Rapid Diagnostic Tests (RDTs), and advanced molecular diagnostic methods such as PCR and RT-qPCR. These diagnostics are deployed across hospitals and clinics, diagnostic centers, and academic or research institutions to support malaria surveillance, clinical management, and national disease elimination programs. The market’s growth is influenced by the public health burden of malaria in India, government strategies to improve diagnosis and reporting, and ongoing adoption of innovative technologies that ensure faster and more reliable detection.

Market Growth Drivers:

The India malaria diagnostics market is primarily driven by the continued prevalence of malaria in endemic zones and concerted efforts by government healthcare initiatives to improve access to diagnostic tools. Programs such as the National Strategic Plan for Malaria Elimination and state-level initiatives (e.g., DAMaN in Odisha) have increased the distribution of RDTs and supported active community-level surveillance. Strategic partnerships between government agencies, international organizations like the World Health Organization (WHO) and The Global Fund, and private healthcare providers have further strengthened the availability and affordability of diagnostic solutions. These collaborations have improved access to both basic and advanced diagnostic technologies across diverse regions.

The shift toward advanced molecular diagnostic techniques, including PCR and RT-qPCR, is another key growth driver. These technologies offer enhanced sensitivity and specificity compared to traditional methods, enabling better detection of low-density and asymptomatic infections that are often missed by conventional diagnostic practices. This capability is crucial in low-endemic zones and urban tertiary care settings where precise diagnosis supports effective treatment and surveillance.

Market Restraints:

Despite positive growth trends, the market faces notable challenges. Traditional microscopy, historically considered the gold standard for malaria diagnosis, has limitations in sensitivity-particularly in detecting infections with low parasite densities. Studies indicate that microscopy can miss a significant proportion of cases, especially in low-endemic and asymptomatic populations, thereby impeding effective disease control efforts. Additionally, the high cost and infrastructure requirements of molecular diagnostic technologies may hinder their rapid adoption across all healthcare settings, especially in rural and resource-limited regions.

Additionally, gaps in disease reporting-especially due to fragmented data from private healthcare providers and reliance on paper-based systems in some regions-pose challenges for comprehensive surveillance and timely outbreak detection.

Market Opportunities:

The India malaria diagnostics market presents significant opportunities driven by advancements in genomic surveillance and diagnostics. Next-Generation Sequencing (NGS) is emerging as a valuable tool for high-resolution genetic analysis of Plasmodium strains, enabling detailed monitoring of drug resistance profiles and regional epidemiology. Such genomic insights support targeted antimalarial strategies and tailored public health responses. Collaborative research initiatives-such as those under the India International Centers of Excellence for Malaria Research (ICEMR)-are leveraging NGS and other advanced tools to improve understanding of parasite diversity and resistance patterns.

The expanding adoption of RDTs continues to create growth potential, particularly in remote and underserved areas where rapid, point-of-care testing is essential. RDTs are valued for their ability to deliver quick results (typically within 15–30 minutes) without requiring sophisticated laboratory infrastructure, making them especially useful in rural and tribal regions with limited access to healthcare facilities.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the India malaria diagnostics market?
• Which diagnostic technologies are witnessing the highest adoption and why?
• How are technological innovations reshaping malaria detection and surveillance in India?
• Who are the leading players in the India malaria diagnostics market, and what strategies are they using to stay competitive?
• What are the emerging trends and future prospects for malaria diagnostics through 2032?

Competitive Intelligence and Business Strategy:

The India malaria diagnostics market comprises a competitive mix of multinational diagnostic corporations, domestic manufacturers, and specialized biotech firms. Leading global players such as Bio-Rad Laboratories Inc., Access Bio Inc., Abbott India Limited, Hologic, Inc., and Roche Diagnostics India Pvt. Ltd. are expanding their product offerings and customizing diagnostic solutions for the Indian market. These companies leverage global expertise to introduce high-performance RDTs and molecular diagnostic kits tailored to local disease patterns and healthcare needs.

Domestic companies like MicroGene Diagnostic Systems (P) Ltd, Premier Medical, and others focus on producing cost-effective and accessible diagnostic kits designed to function efficiently under India’s varied climatic and infrastructural conditions. Strategic collaborations with public health authorities, private healthcare chains, and international partners help enhance market penetration and ensure broader diagnostic coverage.

Key Companies Profiled:

• Bio-Rad Laboratories Inc.
• Access Bio Inc.
• Abbott India Limited
• Hologic, Inc.
• Roche Diagnostics India Pvt. Ltd.
• Sysmex India Private Limited
• Becton Dickinson India Private Limited
• Siemens Healthineers AG
• Meridian Bioscience, Inc.
• Olympus Corporation
• Nikon India Pvt Ltd
• Beckman Coulter, Inc.
• MicroGene Diagnostic Systems (P) Ltd
• Premier Medical
• BIOMÉRIEUX

Key Segments Covered in India Malaria Diagnostics Industry Research:

By Technology:
• Microscopy
• Rapid Diagnostic Tests (RDTs)
• Molecular Diagnostic Tests (PCR, RT-qPCR)

By End-use:
• Hospitals and Clinics
• Diagnostic Centers
• Academic and Research Institutions

By Region:
• East India
• North India
• West India

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. India Malaria Diagnostics Market Snapshot, 2025 and 2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Macro-economic Factors
2.3.1. Public Health Funding and Government Initiatives
2.3.2. International Health Collaborations and FDI in Healthcare
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
3.1. Regulatory Landscape
3.2. Value Chain Analysis
3.3. PESTLE Analysis
3.4. Porter’s Five Force Analysis
4. Price Trend Analysis 2019 - 2032
4.1. Key Highlights
4.2. Key Factors Impacting Technology Costs
4.3. Pricing Analysis by End Use
5. India Malaria Diagnostics Market Outlook
5.1. India Malaria Diagnostics Market Outlook: Technology
5.1.1. Introduction / Key Findings
5.1.2. Historical Market Technology Provider (US$ Mn) and Analysis, By Technology, 2019-2024
5.1.3. Current Market Technology Provider (US$ Mn) and Analysis and Forecast, By Technology, 2025-2032
5.1.3.1. Microscopy
5.1.3.2. Rapid Diagnostic Tests (RDTs)
5.1.3.3. Molecular Diagnostic Tests
5.1.3.3.1. Conventional PCR
5.1.3.3.2. Modernized PCR
5.2. Market Attractiveness Analysis: Technology
5.3. India Malaria Diagnostics Market Outlook: End Use
5.3.1. Introduction / Key Findings
5.3.2. Historical Market Technology Provider (US$ Mn) Analysis, By End Use, 2019-2024
5.3.3. Current Market Technology Provider (US$ Mn) Analysis and Forecast, By End Use, 2025-2032
5.3.3.1. Hospitals and Clinics
5.3.3.2. Diagnostic Centers
5.3.3.3. Academic and Research Institutions
5.4. Market Attractiveness Analysis: End Use
6. India Malaria Diagnostics Market Outlook: Region
6.1. Key Highlights
6.2. Historical Market Technology Provider (US$ Mn) Analysis, By Region, 2019-2024
6.3. Current Market Technology Provider (US$ Mn) Analysis and Forecast, By Region, 2025-2032
6.3.1. North India
6.3.2. West India
6.3.3. South India
6.3.4. East India
6.4. Market Attractiveness Analysis: By Region
7. Competition Landscape
7.1. Market Share Analysis, 2023
7.2. Market Structure
7.2.1. Competition Intensity Mapping
7.2.2. Competition Dashboard
7.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
7.3.1. Bio-Rad Laboratories Inc.
7.3.1.1. Overview
7.3.1.2. Solution Portfolio
7.3.1.3. Key Financials
7.3.1.4. Market Developments
7.3.1.5. Market Strategy
7.3.2. Access Bio Inc.
7.3.3. Abbott India Limited
7.3.4. Hologic, Inc.
7.3.5. Roche Diagnostics India Pvt. Ltd.
7.3.6. Sysmex India Private Limited
7.3.7. Becton Dickinson India Private Limited
7.3.8. Siemens Healthineers AG
7.3.9. Meridian Bioscience, Inc.
7.3.10. Olympus Corporation
7.3.11. Nikon India Pvt Ltd
7.3.12. Beckman Coulter, Inc.
7.3.13. MicroGene Diagnostic Systems (P) Ltd
7.3.14. Premier Medical
7.3.15. BIOMÉRIEUX
7.3.16. Others
8. Appendix
8.1. Research Methodology
8.2. Research Assumptions
8.3. Acronyms and Abbreviations